Published August 7, 2009

Natural extract stops dry eyes and dry mouth

Did you know that as many as four million Americans suffer from dry eyes and dry mouth? Did you also know this common disorder affects mostly people over the age of 50? And it has a very scary sounding name — Sjogren’s Syndrome. But there’s no reason to be afraid of this, as there’s a very simple treatment for it — and you may have it sitting in your kitchen.

Most doctors consider Sjogren’s Syndrome an autoimmune disease. It is often a secondary problem to other inflammatory processes. In Sjogren’s specifically, inflammatory cells accumulate in tear and saliva glands. The resulting inflammation can destroy your normal cells. In my view, your own cells aren’t really under attack. The immune cells sense something else there and your normal cells are innocent bystanders in the war. Wouldn’t it be great to find something to tone down the inflammation?

Read More

Published August 5, 2009

Did Big Pharma Just Try to Create a Mutant Flu Pandemic?

With all the media focus on a possible government takeover of health care, there’s something that scares me even more. There is open talk of forced vaccinations for the swine flu.

Don’t think it’s possible? Think again. I just saw a news report that the military has offered to assist in the event of a swine flu outbreak. Why the military? And why over what has been a relatively benign disease so far?

Read More

Published July 31, 2009

What to do when drugs cause unexpected health problems

In a rare court ruling that pleases me, the U.S. Supreme court upheld damages for a woman injured by one of Big Pharma’s drugs. And this decision is extremely important to you.

A Vermont woman received an intravenous injection of the drug Phenergan, which the FDA approved years ago. The drug found its way into her artery and caused gangrene. She lost her right arm. She brought suit claiming that the drug maker, Wyeth, should have had more stern warnings about injection of the drug on the label. The FDA approves of such warnings.

Here was the problem. The FDA might not go far enough in stressing a warning. An injury could occur that might not have otherwise happened if the label carried full disclosure of the known risks. Wyeth argued that since the FDA approved the label, the company should be immune from attack. The court held that such defense would apply only if the issue was presented to the FDA and the agency rejected the proposed warning.

Read More